<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25985" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Normochromic Normocytic Anemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yilmaz</surname>
            <given-names>Gizem</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shaikh</surname>
            <given-names>Hira</given-names>
          </name>
          <aff>University of Cincinnati Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gizem Yilmaz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hira Shaikh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25985.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Normocytic normochromic anemia is a type of anemia in which the circulating red blood cells (RBCs) are the same size (normocytic) and have a normal red color (normochromic). Most normochromic anemias are a consequence of other diseases; a minority reflect a primary disorder of the blood. Management depends primarily on treating the underlying cause of anemia. This activity will focus on the role of the interprofessional team in diagnosing and managing normocytic normochromic anemia.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of normocytic normochromic anemia.</p></list-item><list-item><p>Assess&#x000a0;the pathophysiology of normocytic normochromic anemia.</p></list-item><list-item><p>Evaluate&#x000a0;the management of the normocytic normochromic anemia-related disease.</p></list-item><list-item><p>Communicate&#x000a0;the role of the interprofessional team in diagnosing and managing normocytic normochromic anemia to ensure the best patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25985&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25985">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25985.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Anemia is a condition marked by&#x000a0;a decrease in red blood cells (RBC), the proportion of hemoglobin, or the collective volume of packed RBCs (hematocrit). The main function&#x000a0;of RBCs, or erythrocytes, is to carry oxygen from the lungs to the body tissues and carbon dioxide as a waste product from the body tissues to the lungs. This process is facilitated by hemoglobin. A decrease in the number of RBCs transporting oxygen and carbon dioxide in anemia decreases the body&#x02019;s capacity for proper gas exchange. The impairment may result from blood loss, increased destruction, or reduced production of RBCs. Traditionally, the decrease is quantified by the ratio of packed RBCs to blood volume, called hematocrit and hemoglobin concentration.<xref ref-type="bibr" rid="article-25985.r1">[1]</xref><xref ref-type="bibr" rid="article-25985.r2">[2]</xref></p>
        <p>Anemia can be classified according to mean corpuscular volume (MCV), a measure of the average volume of RBCs in a specimen. Low MCV indicates microcytic, normal MCV indicates normocytic, and high MCV indicates macrocytic.<xref ref-type="bibr" rid="article-25985.r3">[3]</xref>&#x000a0;Anemia is generally defined as hemoglobin of less than 13.0 g/dL in men and less than 12.0 g/dL in premenopausal women.<xref ref-type="bibr" rid="article-25985.r4">[4]</xref>&#x000a0;Normocytic normochromic anemia differs from other forms of anemia because the RBCs' average size and hemoglobin content are typically within normal limits. RBCs typically&#x000a0;appear similar to normal cells under microscopic examination. In some&#x000a0;cases, variations in size and shape may equalize&#x000a0;1 another, resulting in average values within the normal range. Normocytic normochromic anemia most commonly occurs due to miscellaneous chronic infections and systemic diseases. Most normocytic anemias appear to be the outcome of the impaired production of RBCs.<xref ref-type="bibr" rid="article-25985.r5">[5]</xref></p>
      </sec>
      <sec id="article-25985.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most normochromic, normocytic anemias are a consequence of other diseases; a minority reflects a primary disorder of the blood.&#x000a0;This may be due to anemia of chronic disease (inflammation, neoplasia), renal failure, endocrine failure (hypothyroidism, hypopituitarism), marrow failure (pure red-cell aplasia, aplastic anemia, infiltration), acute blood loss, and polymyalgia rheumatica.<xref ref-type="bibr" rid="article-25985.r6">[6]</xref>&#x000a0;The etiology of normocytic normochromic anemia depends on whether the anemia is hypoproliferative (ie, corrected reticulocyte count &#x0003c;2%) or&#x000a0;hyperproliferative (ie, corrected reticulocyte count &#x0003e;2%).<xref ref-type="bibr" rid="article-25985.r7">[7]</xref><xref ref-type="bibr" rid="article-25985.r8">[8]</xref></p>
        <p>
<bold>Normal/Decreased Reticulocyte Count</bold>
</p>
        <p>
<bold>Normal bone marrow</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anemia of chronic disorders (neoplastic, infections)</p>
          </list-item>
          <list-item>
            <p>Anemia of renal failure</p>
          </list-item>
          <list-item>
            <p>Endocrinopathy (myxedema, Addison disease, hypothyroidism, panhypopituitarism)</p>
          </list-item>
          <list-item>
            <p>Anemia of liver disease</p>
          </list-item>
          <list-item>
            <p>Early iron-deficiency anemia</p>
          </list-item>
        </list>
        <p>
<bold>Abnormal bone marrow</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Marrow infiltration (leukemia, myelofibrosis, metastasis)</p>
          </list-item>
          <list-item>
            <p>Hypoplastic anemia</p>
          </list-item>
          <list-item>
            <p>Aplastic anemia</p>
          </list-item>
          <list-item>
            <p>Medication side effect</p>
          </list-item>
        </list>
        <p>
<bold>Increased Reticulocyte&#x000a0;Count</bold>
</p>
        <p>
<bold>Hemolysis</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Intrinsic: Inherited defects of hemoglobin, RBC membrane, or enzyme;&#x000a0;paroxysmal nocturnal hemoglobinuria</p>
          </list-item>
          <list-item>
            <p>Extrinsic: Autoimmune hemolytic anemia, microangiopathic hemolytic anemia, disseminated intravascular coagulation</p>
          </list-item>
        </list>
        <p>
<bold>Hemorrhage</bold>
</p>
      </sec>
      <sec id="article-25985.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epidemiologic data are not available for all conditions associated with normocytic normochromic anemia, taking together the most common cause of&#x000a0;normocytic normochromic anemia is anemia of chronic disease; a summary by Wiess et al shows the estimated prevalence percentage of underlying causes of&#x000a0;anemia of chronic disease (infections 18% to 95%, cancer 30% to 77%, autoimmune 8% to 71%, chronic rejection after solid organ transplantation 8&#x000a0;to 71% and chronic kidney disease and inflammation 23% to 50%. Nevertheless, the prevalence of normocytic normochromic anemia in patients with less common causes like endocrine failure, marrow failure, acute blood loss, etc, is not well defined.<xref ref-type="bibr" rid="article-25985.r9">[9]</xref></p>
      </sec>
      <sec id="article-25985.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenetic mechanisms of normocytic normochromic anemia vary; specifics depend largely on the etiological cause. Several factors play a role in the cumulative cause of the anemia. Since chronic disease anemia constitutes a major percentage of normocytic normochromic anemia cases and has a common pathophysiology with other causes of normocytic normochromic anemia, in the following section, we refer primarily to the common pathways involved in anemia of chronic disease, along with other associated conditions.</p>
        <p>Anemia of chronic disease is usually mild to moderate normocytic normochromic anemia; it evolves with time to become hypochromic and, more rarely, microcytic. Less than 25% of normocytic normochromic anemia cases progress to microcytic hypochromic anemia, where the mean corpuscular volume is rarely less than 70.<xref ref-type="bibr" rid="article-25985.r9">[9]</xref>&#x000a0;This measure contrasts with iron deficiency anemia, which is mostly microcytic. The hemoglobin concentration is usually 8 g/dL to 9.5 g/dL (mild to moderate anemia) and rarely drops below 6 g/dL. In cases of severe anemia, other causes of red cell loss or destruction should be strongly considered. Anemia&#x000a0;of chronic disease may be secondary to infections, malignancies, autoimmune disorders, or chronic renal failure.&#x000a0;</p>
        <p>The pathophysiology of normocytic normochromic anemia is complex. Still, it typically relates to&#x000a0;3 broad causes, each related to&#x000a0;an increase in pro-inflammatory cytokines and a subsequent increase in hepcidin levels. In addition, inappropriate&#x000a0;erythropoietin (EPO) levels, a decreased response to erythropoietin, and decreased RBC survival contribute to normocytic normochromic anemia. This is the underlying mechanism most commonly seen in patients with acute renal failure.</p>
        <list list-type="order">
          <list-item>
            <p><bold>Increase in Pro-inflammatory Cytokines and Iron Dysregulation:</bold>&#x000a0;This increase is associated with a variety of disease states, including infection, neoplasm, chronic kidney disease, as well as autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. Hepcidin is the main modulator of iron metabolism, which is key in chronic disease and anemia pathophysiology. Interleukin-6 (IL-6) and other proinflammatory cytokines facilitate an acute-phase protein, hepcidin upregulation. Hepcidin binds to the iron export protein, ferroportin, in macrophages, hepatocytes, and enterocytes. Increased hepcidin levels lead to iron trapping within macrophages and hepatocytes, resulting in low circulating iron levels. Through negative feedback stimulated by increased iron stores, hepcidin causes enterocytes and macrophages to degrade ferroportin, thus reducing absorption and promoting storage.<xref ref-type="bibr" rid="article-25985.r10">[10]</xref><xref ref-type="bibr" rid="article-25985.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Inappropriate EPO Levels or Less Response&#x000a0;to Erythropoietin:</bold>&#x000a0;In a healthy individual, erythropoietin circulates in the bone marrow to assist in producing RBCs, thereby improving oxygen concentration in the blood and relieving hypoxia. Recent studies have identified many cytokines that inhibit hemopoiesis in the bone marrow and contribute to a subnormal erythropoietin response, varying by the degree of anemia. For example, in patients with chronic kidney disease, anemia is mainly due to a deficiency of EPO. Because kidney function plays an important role in hepcidin clearance, kidney dysfunction leads to decreased hepcidin clearance and consequent hepcidin storage, resulting in hyposideremic anemia development<bold>.</bold><xref ref-type="bibr" rid="article-25985.r12">[12]</xref>&#x000a0;Several inflammatory proteins and the inflammatory cytokine, especially IL-6, have been linked to this diminished response to erythropoietin. These cytokines downregulate the expression of the SLC4a1 gene in late erythroid precursors, thereby reducing hemoglobin synthesis. This process results&#x000a0;in the escalation of the hepatic synthesis of hepcidin.<xref ref-type="bibr" rid="article-25985.r13">[13]</xref><xref ref-type="bibr" rid="article-25985.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Decreased&#x000a0;RBC Survival and&#x000a0;</bold><bold><bold>Bone Marrow Infiltration:&#x000a0;</bold></bold>Several studies have identified a mild shortening of the red-cell lifespan in normocytic normochromic anemia cases, which appears to be due to an extracorpuscular factor or intrinsic abnormality of the red cells. The RBC survival is usually not markedly shortened, and marrow function should compensate for the reduced survival. In hemolytic anemias, the etiology of premature erythrocyte destruction is diverse and can be due to conditions such as intrinsic membrane defects, abnormal hemoglobin, erythrocyte enzymatic defects, immune destruction of erythrocytes, mechanical injury, and hypersplenism. Hemolysis may also be intramedullary, occurring when fragile red blood cell (RBC) precursors are destroyed in the bone marrow before they are released into circulation.<xref ref-type="bibr" rid="article-25985.r15">[15]</xref>&#x000a0;Bone marrow changes also lead to physical obstruction and destruction of the bone marrow microenvironment.</p>
          </list-item>
        </list>
        <p>Anemia secondary to cancers occurs via these&#x000a0;common&#x000a0;mechanisms: decreased production of RBCs, increased&#x000a0;RBC destruction, blood loss, or miscellaneous etiologies. However, in some cases, significant anemia has also been observed in the absence of marrow invasion or deficiency&#x000a0;of vital nutrients. This signifies that other pathways may be important in the pathogenetic processes leading to anemia, cancers, or marrow&#x000a0;changes that lead to physical obstruction and bone marrow microenvironment destruction.<xref ref-type="bibr" rid="article-25985.r16">[16]</xref></p>
      </sec>
      <sec id="article-25985.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The RBCs' average size and hemoglobin content are within the normal range in typical normocytic normochromic anemia cases. Under microscopic examination, RBCs usually appear similar to normal cells. However, remarkable variations in each cell size and shape may be detectable in some cases, causing&#x000a0;normal average values.<xref ref-type="bibr" rid="article-25985.r17">[17]</xref>&#x000a0;Bone marrow morphology can help us differentiate various types of anemia:</p>
        <list list-type="order">
          <list-item>
            <p>Normal morphology: Secondary anemia (inflammation, renal disease, renal disease, endocrine deficiency, etc)</p>
          </list-item>
          <list-item>
            <p>Hypoplastic: Aplastic anemia</p>
          </list-item>
          <list-item>
            <p>Infiltration/fibrosis: Leukemia, myelofibrosis, metastases</p>
          </list-item>
          <list-item>
            <p>Dyserythropoetic: Myelodysplasia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25985.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Taking a medical history is&#x000a0;1 of the first things a healthcare provider requires to diagnose anemia.&#x000a0;Symptoms of normocytic anemia can be&#x000a0;slow to develop depending on the causation.</p>
        <p>
<bold>Common Symptoms</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Fatigue</p>
          </list-item>
          <list-item>
            <p>Dizziness or lightheadedness</p>
          </list-item>
          <list-item>
            <p>Dyspnea</p>
          </list-item>
          <list-item>
            <p>Exercise intolerance</p>
          </list-item>
          <list-item>
            <p>Generalized weakness</p>
          </list-item>
          <list-item>
            <p>Palpitation</p>
          </list-item>
          <list-item>
            <p>Headaches</p>
          </list-item>
          <list-item>
            <p>Decreased concentration</p>
          </list-item>
        </list>
        <p>
<bold>Important History Questions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Diet</p>
          </list-item>
          <list-item>
            <p>History of abdominal pain, reflux disease, peptic ulcer disease</p>
          </list-item>
          <list-item>
            <p>Medications, including frequent use of nonsteroidal anti-inflammatory drugs</p>
          </list-item>
          <list-item>
            <p>History of autoimmune conditions, malignancies</p>
          </list-item>
          <list-item>
            <p>Blood loss, including menstrual history (eg, hematochezia, melena stools, gross hematuria, hematemesis)</p>
          </list-item>
          <list-item>
            <p>Family history of thalassemia or sickle cell disease&#x000a0;<xref ref-type="bibr" rid="article-25985.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Medications</p>
          </list-item>
        </list>
        <p>A physical exam may help confirm the diagnosis. The first signs of normocytic normochromic anemia or any type&#x000a0;of anemia are usually generalized weakness&#x000a0;and a pale complexion.</p>
        <p>
<bold>Physical Exam Signs</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The pallor of the skin, conjunctivae, lips, palmar creases, and nail beds</p>
          </list-item>
          <list-item>
            <p>Postural hypotension secondary to intravascular volume loss</p>
          </list-item>
          <list-item>
            <p>Jaundice caused by hemolytic anemia</p>
          </list-item>
          <list-item>
            <p>Bone pain or organomegaly with an infiltrative disease of the bone marrow</p>
          </list-item>
          <list-item>
            <p>Splenomegaly secondary to hemolysis, lymphoma, leukemia, myelofibrosis&#x000a0;<xref ref-type="bibr" rid="article-25985.r19">[19]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25985.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The common workup required to diagnose normocytic normochromic anemia includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Complete blood count&#x000a0;with differential&#x02014;repeat if there is an acute drop; rule out any dilutional effect. This is usually observed in a patient receiving a substantial amount of fluids in a short period of time and is associated with an equal drop in other cell lines.</p>
          </list-item>
          <list-item>
            <p>MCV and mean corpuscular hemoglobin concentration</p>
          </list-item>
        </list>
        <p>Reticulocyte count&#x000a0;must be obtained to determine the pathophysiologic mechanism of anemia. Increased reticulocyte&#x000a0;count&#x000a0;demonstrates hemolysis; other evidence&#x000a0;related&#x000a0;to increased RBC destruction, eg, increased LDH, increased indirect bilirubin level, decreased haptoglobin, etc, should also be considered. A decreased reticulocyte count&#x000a0;is associated with a hypoproliferative state like aplastic anemias, kidney disease, hypothyroidism, etc.</p>
        <list list-type="bullet">
          <list-item>
            <p>Corrected reticulocyte count = percent reticulocytes x (patient's hematocrit/normal hematocrit)</p>
          </list-item>
          <list-item>
            <p>Peripheral smear - Erythrocyte morphology (shape and size; absence&#x000a0;of schistocytes rules out microangiopathic hemolysis; microspherocytes indicate hemolysis; rouleaux formation relates to&#x000a0;multiple myeloma.</p>
          </list-item>
          <list-item>
            <p>Lactate dehydrogenase, haptoglobin, bilirubin - to rule out hemolysis</p>
          </list-item>
          <list-item>
            <p>Iron panel (iron, ferritin, total iron binding capacity, transferrin saturation)&#x000a0;<xref ref-type="bibr" rid="article-25985.r8">[8]</xref>&#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <p>If normocytic normochromic anemia with a secondary cause is suspected, the following tests should be done as per diagnosis/clinical suspicion:</p>
        <list list-type="bullet">
          <list-item>
            <p>Renal failure: BUN/creatinine, erythropoietin level (end-stage renal disease)</p>
          </list-item>
          <list-item>
            <p>Autoimmune causes: antinuclear antibody, erythrocyte sedimentation rate, C-reactive protein, and other studies depending on symptoms and signs</p>
          </list-item>
          <list-item>
            <p>Hypothyroidism: Thyroid function tests</p>
          </list-item>
          <list-item>
            <p>Multiple myeloma: Serum and urine electrophoresis, serum and urine-free light chains</p>
          </list-item>
          <list-item>
            <p>Aplastic anemia: Drug exposure, infections (Epstein-Barr virus, hepatitis, cytomegalovirus, human immunodeficiency virus, parvovirus), hematologic malignancies, and paroxysmal nocturnal hemoglobinuria</p>
          </list-item>
          <list-item>
            <p>Pure red cell aplasia: Test for parvovirus B19, exclude thymoma&#x000a0;<xref ref-type="bibr" rid="article-25985.r20">[20]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25985.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of normocytic normochromic anemia depends primarily on treating the underlying cause of anemia. Blood transfusion remains an important short-term management option, especially in individuals with severe anemia (hemoglobin &#x0003c;7 g/dL), those who are symptomatic or have&#x000a0;associated cardiac disease.<xref ref-type="bibr" rid="article-25985.r21">[21]</xref></p>
        <p><bold>Anemia of Chronic Disease:</bold>&#x000a0;Treatment of the anemia of chronic disease requires treating the&#x000a0;underlying disorder. Anemia&#x000a0;of chronic disease is usually mild anemia, but approximately 20% of patients may have hemoglobin &#x0003c;8 g/dl. In these more severe cases, clinicians should rule out additional concurrent causes of anemia, such as iron deficiency anemia. The use of erythropoiesis-stimulating agents, blood transfusion, and iron supplementation to treat the underlying diseases are the most important treatment options. If patients have low or inappropriately normal erythropoietin levels, they may respond to injections of erythropoietin or darbepoetin. Patients with appropriately elevated EPO levels (especially &#x0003e;500 mU/ML) do not respond. The anemia of chronic disease is often mistaken for iron deficiency anemia.<xref ref-type="bibr" rid="article-25985.r22">[22]</xref><xref ref-type="bibr" rid="article-25985.r23">[23]</xref>&#x000a0;It is crucial to differentiate normocytic normochromic anemia from iron deficiency anemia since iron overload&#x000a0;may result in undesirable consequences such as&#x000a0;liver necrosis, seizures, cardiogenic shock, and even coma.<xref ref-type="bibr" rid="article-25985.r24">[24]</xref></p>
        <p><bold>Acute Blood Loss:</bold> Treated with efforts to stop bleeding and supportive measures such as IV fluids, crossmatched packed RBC, and oxygen support.&#x000a0;</p>
        <p><bold>Rheumatoid Arthritis:</bold> Anti-TNF-a antibody has been shown to lessen the severity of anemia.<xref ref-type="bibr" rid="article-25985.r25">[25]</xref>&#x000a0;</p>
        <p><bold>End-stage Renal Disease (ESRD):&#x000a0;</bold>Usually due to decreased renal erythropoietin-stimulating agents, goal&#x000a0;hemoglobin being 10.5-11 g/dl in&#x000a0;ESRD patients withhemoglobin&#x0003c;10 g/dl. ESRD patients with transferrin saturation &#x02264;30% and ferritin &#x02264;500 ng/ml require iron supplementation, preferably with intravenous rather than oral iron.<xref ref-type="bibr" rid="article-25985.r26">[26]</xref></p>
        <p><bold>Primary Bone Marrow Failure:&#x000a0;</bold>Conditions such as aplastic anemia require immunosuppression therapy, bone marrow transplantation, etc.<xref ref-type="bibr" rid="article-25985.r27">[27]</xref></p>
        <p><bold>Hemolytic Anemia:</bold> If caused by faulty mechanical valves (macroangiopathic hemolytic anemia), these need replacement. Hemolytic anemia caused by medications requires the removal of the offending drug. Hemolytic anemia caused by inherited causes is treated depending on the type of disorder. Persistent hemolytic anemia may require splenectomy.</p>
        <p><bold>Hemoglobinopathies:</bold>&#x000a0;Simple blood transfusions, exchange transfusions, hydroxyurea.</p>
        <p><bold>DIC:</bold>&#x000a0;The removal of the offending stimulus. Patients with life-threatening bleeding require the use of antifibrinolytic agents along with blood product transfusions (platelet, plasma, cryoprecipitate).<xref ref-type="bibr" rid="article-25985.r20">[20]</xref></p>
      </sec>
      <sec id="article-25985.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Anemia may not&#x000a0;instantly be evident&#x000a0;on laboratory testing in acute blood loss from trauma since the fluid shifts have&#x000a0;less time to normalize the circulating volume and dilute the remaining RBCs.&#x000a0;</p>
        <p>Significant hemodilution due to large volume fluid resuscitation and phlebotomy hemolysis are other reasons that lead to a falsely low red cell count.<xref ref-type="bibr" rid="article-25985.r28">[28]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Iron deficiency anemia: At earlier stages, it can appear as normocytic normochromic anemia.</p>
          </list-item>
          <list-item>
            <p>Other causes of microcytic anemia: Thalassemia, sideroblastic anemia, and lead poisoning</p>
          </list-item>
          <list-item>
            <p>Macrocytic anemia with B12/folate deficiency</p>
          </list-item>
          <list-item>
            <p>Liver disease: Usually macrocytic anemia</p>
          </list-item>
          <list-item>
            <p>Acute blood loss anemia, esp. upper or lower gastrointestinal bleed</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25985.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Normocytic normochromic anemia is not typically severe, although it can progress with time and with the evolution of the underlying cause. Prognosis is worse when accompanying certain chronic conditions, such as bone marrow failure, autoimmune conditions, or malignancy. Similarly, the prognosis may be altered by a comorbid condition like coronary artery disease, especially in older patients. Likewise, if treated early, anemia due to acute blood loss has a good prognosis. Mortality rates are low in hemolytic anemias.&#x000a0;The etiology of the hemolysis and the underlying disorder, such as sickle cell anemia or malaria, determine&#x000a0;morbidity. In general, the underlying disease is the strongest indication of the prognosis of normocytic normochromic anemia.<xref ref-type="bibr" rid="article-25985.r29">[29]</xref></p>
      </sec>
      <sec id="article-25985.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Most normocytic anemias appear to result from impaired production of red cells or a deficiency of erythropoietin in cases of renal failure. As in the case of anemia associated with chronic infections or various systemic diseases, the symptoms are usually connected to those of the underlying condition, although sometimes anemia may be the most prominent sign. Likewise, the complications differ according to the complication of the underlying disease. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoxia (hypoxic respiratory failure, end-organ damage)</p>
          </list-item>
          <list-item>
            <p>Renal osteodystrophy (in chronic kidney disease, through secondary hyperparathyroidism)</p>
          </list-item>
          <list-item>
            <p>Cardiorenal anemia syndrome: Severe anemia causes a decline in blood perfusion to the kidneys, causing additional kidney damage&#x000a0;<xref ref-type="bibr" rid="article-25985.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Cardiovascular disease</p>
          </list-item>
          <list-item>
            <p>Multiorgan failure</p>
          </list-item>
          <list-item>
            <p>Hepatomegaly, splenomegaly</p>
          </list-item>
          <list-item>
            <p>Jaundice</p>
          </list-item>
        </list>
        <p>
<bold>Anemia Causes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiovascular compromise</p>
          </list-item>
          <list-item>
            <p>Shock</p>
          </list-item>
          <list-item>
            <p>End-organ dysfunction</p>
          </list-item>
          <list-item>
            <p>Functional limitation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25985.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>The patient should be consulted with a hematologist, particularly when a bone marrow disorder or bleeding is present. A nephrologist consultation is crucial if anemia or chronic disease due to renal failure is suspected.</p>
      </sec>
      <sec id="article-25985.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Populations at high risk should be considered for interprofessional evaluation. Patients should work with their healthcare provider to treat the underlying disease, address acute conditions like hemorrhage, and adopt healthy habits. Patients should also receive adequate education about their underlying disease and possible complications of normocytic normochromic anemia.</p>
      </sec>
      <sec id="article-25985.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of normocytic normochromic anemia&#x000a0;require an interprofessional team that includes a primary care provider, an internist, and, if relevant, a hematologist, a gastroenterologist, a gynecologist, a surgeon, and a nurse practitioner, as well as other professional teams. The key is to find the underlying disease and, if already diagnosed, treat and manage it.&#x000a0;After the diagnosis of the underlying disease, appropriate&#x000a0;treatment, in most cases, attenuates the anemia and prevents complications.</p>
      </sec>
      <sec id="article-25985.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25985&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25985">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/normochromic-normocytic-anemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25985">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25985/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25985">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25985.s17">
        <title>References</title>
        <ref id="article-25985.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harteveld</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis of &#x003b1;-thalassemia.</article-title>
            <source>Blood Cells Mol Dis</source>
            <year>2018</year>
            <month>May</month>
            <volume>70</volume>
            <fpage>43</fpage>
            <page-range>43-53</page-range>
            <pub-id pub-id-type="pmid">29032940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veng-Pedersen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Al-Huniti</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Widness</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia.</article-title>
            <source>Pharm Res</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>1630</fpage>
            <page-range>1630-5</page-range>
            <pub-id pub-id-type="pmid">12458668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r3">
          <label>3</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Maner</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Killeen</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Moosavi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <chapter-title>Mean Corpuscular Volume</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>7</month>
            <day>27</day>
            <pub-id pub-id-type="pmid">31424859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <article-title>Nutritional anaemias. Report of a WHO scientific group.</article-title>
            <source>World Health Organ Tech Rep Ser</source>
            <year>1968</year>
            <volume>405</volume>
            <fpage>5</fpage>
            <page-range>5-37</page-range>
            <pub-id pub-id-type="pmid">4975372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stadler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ade</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ritzmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoelzle</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hoelzle</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Detection of a novel haemoplasma species in fattening pigs with skin alterations, fever and anaemia.</article-title>
            <source>Vet Rec</source>
            <year>2020</year>
            <month>Jul</month>
            <day>25</day>
            <volume>187</volume>
            <issue>2</issue>
            <fpage>66</fpage>
            <pub-id pub-id-type="pmid">32332105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fenta</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Nuru</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Yemane</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Asres</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wube</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Anemia and Related Factors Among Highly Active Antiretroviral Therapy Experienced Children in Hawassa Comprehensive Specialized Hospital, Southern Ethiopia: Emphasis on Patient Management.</article-title>
            <source>Drug Healthc Patient Saf</source>
            <year>2020</year>
            <volume>12</volume>
            <fpage>49</fpage>
            <page-range>49-56</page-range>
            <pub-id pub-id-type="pmid">32214854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ward</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Investigation of nonpoikilocytic normochromic normocytic anemia.</article-title>
            <source>Postgrad Med</source>
            <year>1979</year>
            <month>Mar</month>
            <volume>65</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-5, 238, 241-3</page-range>
            <pub-id pub-id-type="pmid">419035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonnet</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Normocytic normochromic anemia.</article-title>
            <source>Postgrad Med</source>
            <year>1977</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>139</fpage>
            <page-range>139-42</page-range>
            <pub-id pub-id-type="pmid">866281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Goodnough</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Anemia of chronic disease.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Mar</month>
            <day>10</day>
            <volume>352</volume>
            <issue>10</issue>
            <fpage>1011</fpage>
            <page-range>1011-23</page-range>
            <pub-id pub-id-type="pmid">15758012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Babitt</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Hepcidin regulation in the anemia of inflammation.</article-title>
            <source>Curr Opin Hematol</source>
            <year>2016</year>
            <month>May</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>189</fpage>
            <page-range>189-97</page-range>
            <pub-id pub-id-type="pmid">26886082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raj</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Role of interleukin-6 in the anemia of chronic disease.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>382</fpage>
            <page-range>382-8</page-range>
            <pub-id pub-id-type="pmid">18336871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaritsky</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Westerman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olbina</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nemeth</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ganz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nissenson</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Salusky</surname>
                <given-names>IB</given-names>
              </name>
            </person-group>
            <article-title>Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>1051</fpage>
            <page-range>1051-6</page-range>
            <pub-id pub-id-type="pmid">19406957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCranor</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cruz</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>QL</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Walston</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Civin</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>CN</given-names>
              </name>
            </person-group>
            <article-title>Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells.</article-title>
            <source>Blood Cells Mol Dis</source>
            <year>2014</year>
            <season>Feb-Mar</season>
            <volume>52</volume>
            <issue>2-3</issue>
            <fpage>126</fpage>
            <page-range>126-33</page-range>
            <pub-id pub-id-type="pmid">24119518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langdon</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Femnou</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>McCranor</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Cheadle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>QL</given-names>
              </name>
              <name>
                <surname>Vaulont</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Civin</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Walston</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>CN</given-names>
              </name>
            </person-group>
            <article-title>Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation.</article-title>
            <source>Am J Hematol</source>
            <year>2014</year>
            <month>May</month>
            <volume>89</volume>
            <issue>5</issue>
            <fpage>470</fpage>
            <page-range>470-9</page-range>
            <pub-id pub-id-type="pmid">24415655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhaliwal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cornett</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Tierney</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Hemolytic anemia.</article-title>
            <source>Am Fam Physician</source>
            <year>2004</year>
            <month>Jun</month>
            <day>01</day>
            <volume>69</volume>
            <issue>11</issue>
            <fpage>2599</fpage>
            <page-range>2599-606</page-range>
            <pub-id pub-id-type="pmid">15202694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaspar</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Anemia in malignancies: pathogenetic and diagnostic considerations.</article-title>
            <source>Hematology</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-25</page-range>
            <pub-id pub-id-type="pmid">24666207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vo</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kollsete Gjelberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hovland</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lindstad Bratt&#x000e5;s</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Bruserud</surname>
                <given-names>&#x000d8;</given-names>
              </name>
              <name>
                <surname>Reikvam</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment.</article-title>
            <source>Case Rep Hematol</source>
            <year>2020</year>
            <volume>2020</volume>
            <fpage>1262038</fpage>
            <pub-id pub-id-type="pmid">32082654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broadway-Duren</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Klaassen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Anemias.</article-title>
            <source>Crit Care Nurs Clin North Am</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>411</fpage>
            <page-range>411-26, v</page-range>
            <pub-id pub-id-type="pmid">24267278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strobach</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Doll</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Ringenberg</surname>
                <given-names>QS</given-names>
              </name>
            </person-group>
            <article-title>The value of the physical examination in the diagnosis of anemia. Correlation of the physical findings and the hemoglobin concentration.</article-title>
            <source>Arch Intern Med</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>148</volume>
            <issue>4</issue>
            <fpage>831</fpage>
            <page-range>831-2</page-range>
            <pub-id pub-id-type="pmid">3355303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Turner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Parsi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Badireddy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Anemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">29763170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Ovsyannikova</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Haralambieva</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Pankratz</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Poland</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.</article-title>
            <source>Immunogenetics</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>66</volume>
            <issue>7-8</issue>
            <fpage>493</fpage>
            <page-range>493-9</page-range>
            <pub-id pub-id-type="pmid">24811271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Madu</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Ughasoro</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Anaemia of Chronic Disease: An In-Depth Review.</article-title>
            <source>Med Princ Pract</source>
            <year>2017</year>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">27756061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schett</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Anaemia in inflammatory rheumatic diseases.</article-title>
            <source>Nat Rev Rheumatol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>205</fpage>
            <page-range>205-15</page-range>
            <pub-id pub-id-type="pmid">23147894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Yuen</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <chapter-title>Iron Toxicity</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29083637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doyle</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giles</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bingham</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Bathon</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-31</page-range>
            <pub-id pub-id-type="pmid">18823645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Besarab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coyne</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Iron supplementation to treat anemia in patients with chronic kidney disease.</article-title>
            <source>Nat Rev Nephrol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>12</issue>
            <fpage>699</fpage>
            <page-range>699-710</page-range>
            <pub-id pub-id-type="pmid">20956992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peslak</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Babushok</surname>
                <given-names>DV</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Aplastic Anemia.</article-title>
            <source>Curr Treat Options Oncol</source>
            <year>2017</year>
            <month>Nov</month>
            <day>16</day>
            <volume>18</volume>
            <issue>12</issue>
            <fpage>70</fpage>
            <pub-id pub-id-type="pmid">29143887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Androne</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>LaManca</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hudaihed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hryniewicz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Hemodilution is common in patients with advanced heart failure.</article-title>
            <source>Circulation</source>
            <year>2003</year>
            <month>Jan</month>
            <day>21</day>
            <volume>107</volume>
            <issue>2</issue>
            <fpage>226</fpage>
            <page-range>226-9</page-range>
            <pub-id pub-id-type="pmid">12538419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bedussi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Relli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Faraoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eleftheriou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giampreti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lorenzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sangiovanni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chiara</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maccioni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pilloni</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Falchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scanu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Butera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bacis</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Normocytic Normochromic Anaemia and Asymptomatic Neutropenia in a 40-Day-Old Infant Breastfed by an Epileptic Mother Treated With Lamotrigine: Infant's Adverse Drug Reaction.</article-title>
            <source>J Paediatr Child Health</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>104</fpage>
            <page-range>104-105</page-range>
            <pub-id pub-id-type="pmid">29314386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25985.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Narumi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kadowaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Arimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shishido</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Miyamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Konta</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kubota</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.</article-title>
            <source>Int J Cardiol</source>
            <year>2014</year>
            <month>May</month>
            <day>01</day>
            <volume>173</volume>
            <issue>2</issue>
            <fpage>222</fpage>
            <page-range>222-8</page-range>
            <pub-id pub-id-type="pmid">24630338</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
